Immuno-modulated replication-efficient vaccinia virus strain
US11633441B2 · kind B2 · utility
1Cited by
0References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 3, 2018 |
| Grant date | Apr 25, 2023 |
| Priority date | — |
| Expiry date | Dec 14, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/24143
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention refers to new immuno-modulated replication-efficient Vaccinia virus strain (IOVA) and its derivatives for the use in medicine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.